Back to news

Lisata Therapeutics, Inc. Announces Reverse Stock Split Effective November 23, 2026

Globe Newswire•19/11/2026•09:09 ET
0

Key Highlights

  • ➤One-for-fifteen reverse split effective November 23, 2026
  • ➤Shares outstanding reduced from approximately 10.8 million to 0.7 million
  • ➤LSTA begins split-adjusted Nasdaq trading November 23 under existing symbol

LIBERTY CORNER, N.J., Nov. 19, 2026 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (NASDAQ: LSTA) (“Lisata” or the “Company”) today announced a one-for-fifteen reverse stock split of its common stock. The Company’s common stock will begin trading on a split-adjusted basis on The Nasdaq Capital Market at the market open on November 23, 2026 under the existing trading symbol “LSTA”. The new CUSIP number for the Company’s common stock following the reverse stock split will be 128058 401.

At the Company’s 2026 annual meeting of stockholders held on November 9, 2026, the Company’s stockholders approved an amendment to the Company’s amended and restated certificate of incorporation to effect a reverse stock split of its common stock at a ratio to be determined by the Company’s board of directors within the range from one-for-five to one-for-fifteen. The Company’s board of directors approved the reverse stock split at the ratio of one-for-fifteen.

Get started

Create a free account to read the full story.

Sign Up

Already have an account? Log in